Fosphenytoin Sodium Injection, Solution
Product Images NDC 68462-622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fosphenytoin Sodium (NDC 68462-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-10ml (Carton10ml)

Carton-10ml (Carton10ml)
Packaging label for Fosphenytoin Sodium Injection USP, 500 mg PE/10 mL (50 mg PE/mL) injection solution for intramuscular or intravenous use. The label indicates single-dose vials, 10 vials of 10 mL each, distributed by Glenmark Pharmaceuticals Inc., USA. Product of India, with storage and dosing information included.*
FDA Label Image

Carton2ml (Carton2ml)

Carton2ml (Carton2ml)
Packaging label for Fosphenytoin Sodium Injection, USP 100 mg PE/2 mL (50 mg PE/mL) by Glenmark Pharmaceuticals Inc., USA. The label indicates the product is for intramuscular or intravenous use, contains 25 single-dose 2 mL vials, and is distributed by Glenmark Pharmaceuticals Inc. It also includes storage instructions and dosage information. The NDC is 68462-621-54.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph depicting plasma unbound phenytoin concentration (µg/mL) over time (hours) after the start of infusion. The main graph covers 0 to 2 hours, showing concentration changes with multiple lines, and an inset graph shows concentration changes from 0 to 96 hours after infusion. Both graphs illustrate the pharmacokinetic profile of phenytoin post-infusion.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Fosphenytoin sodium showing its molecular components including phosphate, sodium ions, and characteristic ring structures consistent with its chemical identity as an injectable anticonvulsant agent.*
FDA Label Image

Vial10ml (Vial10ml)

Vial10ml (Vial10ml)
Label for Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL) solution for injection. It is intended for intramuscular or intravenous use. The label states the product is Rx only, in a 10 mL single-dose vial, distributed by Glenmark Pharmaceuticals Inc., USA, and is a product of India. Storage instructions specify refrigeration at 2°C to 8°C.*
FDA Label Image

Vial2ml (Vial2ml)

Vial2ml (Vial2ml)
Fosphenytoin Sodium Injection, USP 100 mg PE/2 mL (50 mg PE/mL) in a 2 mL single-dose vial. The label states the injection is for intramuscular or intravenous use and contains fosphenytoin sodium equivalent to 100 mg phenytoin sodium. Distributed by Glenmark Pharmaceuticals Inc., USA, the product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.